These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Effects of the praziquantel-based control of schistosomiasis japonica in China. Author: Zhou YB, Zhao GM, Jiang QW. Journal: Ann Trop Med Parasitol; 2007 Dec; 101(8):695-703. PubMed ID: 18028731. Abstract: In 2000-2002, the effects of the praziquantel-based control of Schistosoma japonicum (in which each subject found infected in the October of each year is given a single dose of the drug) were examined at 20 or 21 surveillance sites across China. The pre- and post-treatment prevalences and intensities of infection were compared at each site and after pooling using a random-effects method. One year after treatment, in the communities that had the higher prevalences of infection (> 10%) before treatment, the mean prevalence of infection was found to have fallen by 20.15% [95% confidence interval (CI)=6.95%-31.48%] and the geometric mean intensities of infection (measured as eggs/g faeces) in the currently infected individuals and the entire study cohort were found to have fallen, by 22.91% (CI=14.69%-30.34%) and 33.93% (CI=11.69%-50.68%), respectively (P<0.05 for each). In the communities that had lower prevalences of infection pre-treatment, however, no statistically significant reductions in the intensity of infection were observed, although the prevalences in the communities that had pre-treatment prevalences of 6%-10% did fall significantly post-treatment, by a mean of 24.50% (CI=5.35%-39.83%; P<0.05). These observations indicate that the current annual surveys for infection, in which those found infected are each given a single dose of praziquantel, should help keep the prevalence of human infection with S. japonicum low in China, although chemotherapy alone is unlikely to eradicate the parasite.[Abstract] [Full Text] [Related] [New Search]